Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Debt: 2013-2025

Historic Non-Current Debt for Rockwell Medical (RMTI) over the last 9 years, with Sep 2025 value amounting to $8.7 million.

  • Rockwell Medical's Non-Current Debt rose 4.22% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 4.22%. This contributed to the annual value of $8.5 million for FY2024, which is 2.16% up from last year.
  • As of Q3 2025, Rockwell Medical's Non-Current Debt stood at $8.7 million, which was up 1.03% from $8.6 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Non-Current Debt ranged from a high of $21.0 million in Q1 2021 and a low of $3.3 million during Q3 2023.
  • Its 3-year average for Non-Current Debt is $7.4 million, with a median of $8.3 million in 2024.
  • In the last 5 years, Rockwell Medical's Non-Current Debt plummeted by 62.83% in 2023 and then skyrocketed by 151.67% in 2024.
  • Over the past 5 years, Rockwell Medical's Non-Current Debt (Quarterly) stood at $13.2 million in 2021, then tumbled by 42.70% to $7.6 million in 2022, then rose by 9.77% to $8.3 million in 2023, then rose by 2.16% to $8.5 million in 2024, then grew by 4.22% to $8.7 million in 2025.
  • Its last three reported values are $8.7 million in Q3 2025, $8.6 million for Q2 2025, and $8.6 million during Q1 2025.